Stay informed with the latest updates for the inheritable blood disorders community. Industry Alnylam Announces Successful Meeting with FDA on Fitusiran Nov 13, 2017 Industry Study Shows Positive Joint Outcomes in…Nov 6, 2017 Industry FDA Accepts Application for Bayer’s Investigational Hemophilia A TherapyNov 6, 2017 Industry FDA Grants Breakthrough Therapy Designation for…Oct 30, 2017 Industry Shire’s Hemophilia Gene Therapy Granted Orphan Drug Status by FDAOct 27, 2017 Industry UniQure’s Investigational Hemophilia B Gene Therapy to Move Forward in…Oct 20, 2017 Industry Catalyst Reports Positive Results in First…Sep 25, 2017 Industry FDA Accepts License Application and Grants Priority Review for Emicizumab…Sep 8, 2017 Industry Alnylam Reports Patient Death in Fitusiran Clinical StudySep 7, 2017 Industry Bayer Submits Application for Long-Acting FVIII CandidateSep 6, 2017 Industry Sangamo and Pfizer Announce First Patient Treated in Hemophilia…Sep 5, 2017 IndustryFDA Approves Additional Vial Sizes for Nuwiq®Sep 5, 2017 Industry Pfizer to Build Gene Therapy Facility in North CarolinaAug 17, 2017 Industry Spark Reports Preliminary Data from Hemophilia A Gene Therapy Trial Aug 14, 2017 Industry UniQure Escalates Hemophilia B Gene Therapy Manufacturing SiteAug 4, 2017 Pagination First page Previous page … Page 7 Page 8 Page 9 Page 10 Current page 11 Page 12 Page 13 Page 14 Page 15 … Next page Last page
